Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study

Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study

During the coronavirus disease-2019 (COVID-19) pandemic, which was caused by the novel coronavirus, there is an ongoing controversy about the use of corticosteroids. This study aims to investigate the association between Dexamethasone treatment and clinical outcomes in patients with severe COVID-19...

Full description

Bibliographic Details
Main Authors: Mahnaz Montazeri, Marzieh Pazoki, Azar Hadadi, Melika Shafeghat, Abdolazim Veisizadeh, Mohammad Reza Khajavi, Farhad Najmeddin, Samira Kafan
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2022-08-01
Series:Acta Medica Iranica
Subjects:
Coronavirus disease 2019 (COVID-19)
Dexamethasone
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Corticosteroid
Mortality
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/9967

Internet

https://acta.tums.ac.ir/index.php/acta/article/view/9967

Similar Items